Genome Editing Market By Delivery Method (Ex-vivo and In-vivo), By Technology (CRISPR/Cas9, Meganuclease, TALENs/MegaTALs, ZFN, and Others), By Application (Genetic Engineering (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering, and Others) and Clinical Applications (Diagnostics and Therapy Development)), By End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Jan 2025
- Report ID: 138474
- Number of Pages: 221
- Format:
-
-
-
- Sangamo Therapeutics
- Recombinetics
- Precision BioSciences
- LGC
- Editas Medicine
- CRISPR Therapeutics
- Cellectis
- AstraZeneca Plc Company Profile
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible